Ionis Pharmaceuticals, Inc. (IONS)
62.03
+2.29
(+3.83%)
USD |
NASDAQ |
Aug 24, 16:00
61.98
-0.05
(-0.08%)
After-Hours: 20:00
Ionis Pharmaceuticals Total Return Level : 59.74 for Aug. 21, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 21, 2026 | 59.74 |
| August 20, 2026 | 58.76 |
| August 19, 2026 | 60.80 |
| August 18, 2026 | 59.62 |
| August 17, 2026 | 58.63 |
| August 14, 2026 | 57.24 |
| August 13, 2026 | 55.87 |
| August 12, 2026 | 56.53 |
| August 11, 2026 | 55.42 |
| August 10, 2026 | 56.94 |
| August 07, 2026 | 56.56 |
| August 06, 2026 | 54.49 |
| August 05, 2026 | 54.19 |
| August 04, 2026 | 55.07 |
| August 03, 2026 | 54.49 |
| July 31, 2026 | 51.77 |
| July 30, 2026 | 53.28 |
| July 29, 2026 | 54.04 |
| July 28, 2026 | 55.30 |
| July 27, 2026 | 55.96 |
| July 24, 2026 | 56.55 |
| July 23, 2026 | 55.87 |
| July 22, 2026 | 54.01 |
| July 21, 2026 | 53.39 |
| July 20, 2026 | 52.95 |
| Date | Value |
|---|---|
| July 17, 2026 | 54.39 |
| July 16, 2026 | 54.65 |
| July 15, 2026 | 54.73 |
| July 14, 2026 | 54.93 |
| July 13, 2026 | 56.75 |
| July 10, 2026 | 58.25 |
| July 09, 2026 | 64.27 |
| July 08, 2026 | 84.46 |
| July 07, 2026 | 86.33 |
| July 06, 2026 | 83.18 |
| July 02, 2026 | 81.80 |
| July 01, 2026 | 79.19 |
| June 30, 2026 | 79.29 |
| June 29, 2026 | 80.69 |
| June 26, 2026 | 81.18 |
| June 25, 2026 | 78.34 |
| June 24, 2026 | 76.52 |
| June 23, 2026 | 75.99 |
| June 22, 2026 | 75.89 |
| June 18, 2026 | 74.12 |
| June 17, 2026 | 74.31 |
| June 16, 2026 | 73.09 |
| June 15, 2026 | 73.96 |
| June 12, 2026 | 73.28 |
| June 11, 2026 | 73.82 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Alnylam Pharmaceuticals, Inc. | 236.22 |
| Biogen, Inc. | 216.78 |
| BridgeBio Pharma, Inc. | 81.50 |
| Vertex Pharmaceuticals, Inc. | 548.05 |
| Arrowhead Pharmaceuticals, Inc. | 87.11 |